Cargando…

Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines

BACKGROUND: Malaria is one of the most prevalent tropical infectious diseases. Since recently cases of artemisinin resistance were reported, novel anti-malarial drugs are required which differ from artemisinins in structure and biological target. The plasmodial glycogen synthase kinase-3 (PfGSK-3) w...

Descripción completa

Detalles Bibliográficos
Autores principales: Masch, Andreas, Nasereddin, Abed, Alder, Arne, Bird, Megan J., Schweda, Sandra I., Preu, Lutz, Doerig, Christian, Dzikowski, Ron, Gilberger, Tim W., Kunick, Conrad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429710/
https://www.ncbi.nlm.nih.gov/pubmed/30898128
http://dx.doi.org/10.1186/s12936-019-2725-y
_version_ 1783405645928595456
author Masch, Andreas
Nasereddin, Abed
Alder, Arne
Bird, Megan J.
Schweda, Sandra I.
Preu, Lutz
Doerig, Christian
Dzikowski, Ron
Gilberger, Tim W.
Kunick, Conrad
author_facet Masch, Andreas
Nasereddin, Abed
Alder, Arne
Bird, Megan J.
Schweda, Sandra I.
Preu, Lutz
Doerig, Christian
Dzikowski, Ron
Gilberger, Tim W.
Kunick, Conrad
author_sort Masch, Andreas
collection PubMed
description BACKGROUND: Malaria is one of the most prevalent tropical infectious diseases. Since recently cases of artemisinin resistance were reported, novel anti-malarial drugs are required which differ from artemisinins in structure and biological target. The plasmodial glycogen synthase kinase-3 (PfGSK-3) was suggested as a new anti-malarial drug target. 4-Phenylthieno[2,3-b]pyridines were previously identified as selective PfGSK-3 inhibitors with antiplasmodial activity. The present study aims at identifying a molecular position on this scaffold for the attachment of side chains in order to improve solubility and antiplasmodial activity. Furthermore, the role of axial chirality in the compound class for antiplasmodial activity and PfGSK-3 inhibition was investigated. METHODS: 4-Phenylthieno[2,3-b]pyridines with substituents in 4-position of the phenyl ring were docked into the ATP binding site of PfGSK-3. The compounds were synthesized employing a Thorpe reaction as final step. The enantiomers of one congener were separated by chiral HPLC. All derivatives were tested for inhibition of asexual erythrocytic stages of transgenic NF54-luc Plasmodium falciparum. Selected compounds with promising antiplasmodial activity were further evaluated for inhibition of HEK293 cells as well as inhibition of isolated PfGSK-3 and HsGSK-3. The kinetic aqueous solubility was assessed by laser nephelometry. RESULTS: The para position at the 4-phenyl ring of the title compounds was identified as a suitable point for the attachment of side chains. While alkoxy substituents in this position led to decreased antiplasmodial activity, alkylamino groups retained antiparasitic potency. The most promising of these congeners (4h) was investigated in detail. This compound is a selective PfGSK-3 inhibitor (versus the human GSK-3 orthologue), and exhibits improved antiplasmodial activity in vitro as well as better solubility in aqueous media than its unsubstituted parent structure. The derivative 4b was separated into the atropisomers, and it was shown that the (+)-enantiomer acts as eutomer. CONCLUSIONS: The attachment of alkylamino side chains leads to the improvement of antiplasmodial activity and aqueous solubility of selective PfGSK-inhibitors belonging to the class of 4-phenylthieno[2,3-b]pyridines. These molecules show axial chirality, a feature of high impact for biological activity. The findings can be exploited for the development of improved selective PfGSK-3 inhibitors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-019-2725-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6429710
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64297102019-04-04 Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines Masch, Andreas Nasereddin, Abed Alder, Arne Bird, Megan J. Schweda, Sandra I. Preu, Lutz Doerig, Christian Dzikowski, Ron Gilberger, Tim W. Kunick, Conrad Malar J Research BACKGROUND: Malaria is one of the most prevalent tropical infectious diseases. Since recently cases of artemisinin resistance were reported, novel anti-malarial drugs are required which differ from artemisinins in structure and biological target. The plasmodial glycogen synthase kinase-3 (PfGSK-3) was suggested as a new anti-malarial drug target. 4-Phenylthieno[2,3-b]pyridines were previously identified as selective PfGSK-3 inhibitors with antiplasmodial activity. The present study aims at identifying a molecular position on this scaffold for the attachment of side chains in order to improve solubility and antiplasmodial activity. Furthermore, the role of axial chirality in the compound class for antiplasmodial activity and PfGSK-3 inhibition was investigated. METHODS: 4-Phenylthieno[2,3-b]pyridines with substituents in 4-position of the phenyl ring were docked into the ATP binding site of PfGSK-3. The compounds were synthesized employing a Thorpe reaction as final step. The enantiomers of one congener were separated by chiral HPLC. All derivatives were tested for inhibition of asexual erythrocytic stages of transgenic NF54-luc Plasmodium falciparum. Selected compounds with promising antiplasmodial activity were further evaluated for inhibition of HEK293 cells as well as inhibition of isolated PfGSK-3 and HsGSK-3. The kinetic aqueous solubility was assessed by laser nephelometry. RESULTS: The para position at the 4-phenyl ring of the title compounds was identified as a suitable point for the attachment of side chains. While alkoxy substituents in this position led to decreased antiplasmodial activity, alkylamino groups retained antiparasitic potency. The most promising of these congeners (4h) was investigated in detail. This compound is a selective PfGSK-3 inhibitor (versus the human GSK-3 orthologue), and exhibits improved antiplasmodial activity in vitro as well as better solubility in aqueous media than its unsubstituted parent structure. The derivative 4b was separated into the atropisomers, and it was shown that the (+)-enantiomer acts as eutomer. CONCLUSIONS: The attachment of alkylamino side chains leads to the improvement of antiplasmodial activity and aqueous solubility of selective PfGSK-inhibitors belonging to the class of 4-phenylthieno[2,3-b]pyridines. These molecules show axial chirality, a feature of high impact for biological activity. The findings can be exploited for the development of improved selective PfGSK-3 inhibitors. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12936-019-2725-y) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-21 /pmc/articles/PMC6429710/ /pubmed/30898128 http://dx.doi.org/10.1186/s12936-019-2725-y Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Masch, Andreas
Nasereddin, Abed
Alder, Arne
Bird, Megan J.
Schweda, Sandra I.
Preu, Lutz
Doerig, Christian
Dzikowski, Ron
Gilberger, Tim W.
Kunick, Conrad
Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
title Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
title_full Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
title_fullStr Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
title_full_unstemmed Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
title_short Structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
title_sort structure–activity relationships in a series of antiplasmodial thieno[2,3-b]pyridines
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429710/
https://www.ncbi.nlm.nih.gov/pubmed/30898128
http://dx.doi.org/10.1186/s12936-019-2725-y
work_keys_str_mv AT maschandreas structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines
AT nasereddinabed structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines
AT alderarne structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines
AT birdmeganj structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines
AT schwedasandrai structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines
AT preulutz structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines
AT doerigchristian structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines
AT dzikowskiron structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines
AT gilbergertimw structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines
AT kunickconrad structureactivityrelationshipsinaseriesofantiplasmodialthieno23bpyridines